PTH and bacterial infectious disease with sepsis: One subject administered TransCon PTH 32 μg PTH(1‐34) in SAD cohort 3 was withdrawn upon request for personal reasons 2 days early (day 3), whereas one subject administered placebo in SAD cohort 1 was withdrawn 1 day early (day 4) due to a serious adverse event (SAE), ie, bacteremia, assessed by the investigator to be unrelated to study drug.